GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (FRA:6MD) » Definitions » Research & Development

Medacta Group (FRA:6MD) Research & Development : €20.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medacta Group's Research & Development for the six months ended in Dec. 2023 was €10.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €20.3 Mil.

Medacta Group Research & Development Historical Data

The historical data trend for Medacta Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group Research & Development Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 7.64 6.83 11.31 16.22 20.32

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.76 7.73 8.50 9.59 10.73

Medacta Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €20.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medacta Group  (FRA:6MD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medacta Group Research & Development Related Terms

Thank you for viewing the detailed overview of Medacta Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Medacta Group (FRA:6MD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (FRA:6MD) » Definitions » Research & Development
Comparable Companies
XSWX:MED XSWX:KURN ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN XSWX:SOON SHSE:688271 ASX:COH LSE:SN. PODD OCSE:DEMANT BRKR
Traded in Other Exchanges
MOVEz:UK MOVE:Switzerland
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Website
https://www.medacta.com
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.

Medacta Group (FRA:6MD) Headlines

No Headlines